About this document
Meropenem/Vaborbactam for CRE Infections by WilliamRayCassidy is a document available to read on EtoBox.
The document reviews the combination of meropenem and vaborbactam (M/V), a next-generation β-lactam β-lactamase inhibitor, highlighting its efficacy against carbapenem-resistant Enterobacterales (CRE), particularly KPC-producing strains. M/V has shown promising clinical results, favorable pharmacokinetics, and a lower propensity for resistance compared to older therapies, making it a significant option for treating complicated urinary tract infections and other serious infections caused by CRE. The review e
- Author
- WilliamRayCassidy
- Language
- EN